BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 224848)

  • 1. Topical antibiotic therapy of Pseudomonas aeruginosa keratitis.
    Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1979 Sep; 97(9):1699-1702. PubMed ID: 224848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis.
    Tajima K; Miyake T; Koike N; Hattori T; Kumakura S; Yamaguchi T; Matsumoto T; Fujita K; Kuroda M; Ito N; Goto H
    J Infect Chemother; 2014 Jun; 20(6):343-9. PubMed ID: 24726376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topically administered corticosteroids: effect on antibiotic-treated bacterial keratitis.
    Leibowitz HM; Kupferman A
    Arch Ophthalmol; 1980 Jul; 98(7):1287-90. PubMed ID: 7396786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical antibiotic therapy of staphylococcal keratitis.
    Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1977 Sep; 95(9):1634-7. PubMed ID: 901273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic therapy of experimental Pseudomonas keratitis in guinea pigs.
    Davis SD; Sarff LD; Hyndiuk RA
    Arch Ophthalmol; 1977 Sep; 95(9):1638-43. PubMed ID: 197908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of pseudomonas infection of the rabbit cornea. Comparative study.
    Furgiuele FP
    Am J Ophthalmol; 1968 Aug; 66(2):276-9. PubMed ID: 4298724
    [No Abstract]   [Full Text] [Related]  

  • 7. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of gentamicin, tobramycin, polymyxin B, and colistimethate in mouse protection tests with Pseudomonas aeruginosa.
    Davis SD
    Antimicrob Agents Chemother; 1975 Jul; 8(1):50-3. PubMed ID: 169729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Route of antibiotic administration in bacterial keratitis.
    Leibowitz HM; Ryan WJ; Kupferman A
    Arch Ophthalmol; 1981 Aug; 99(8):1420-3. PubMed ID: 6789804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
    Mannis MJ
    Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of mupirocin and polymyxin B in experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens keratitis.
    Moreau JM; Conerly LL; Hume EB; Dajcs JJ; Girgis DO; Cannon BM; Thibodeaux BA; Stroman DW; O'Callaghan RJ
    Cornea; 2002 Nov; 21(8):807-11. PubMed ID: 12410042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selection of drugs in ocular infections antibiotic therapy in corneal ulcer caused by P. aeruginosa].
    Mikuni M; Oishi M; Suda S
    Ganka; 1971 Aug; 13(8):795-802. PubMed ID: 4329687
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
    Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of tobramycin on Pseudomonas keratitis.
    Smolin G; Okumoto M; Wilson FM
    Am J Ophthalmol; 1973 Oct; 76(4):555-60. PubMed ID: 4200625
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic effects of heparin on Pseudomonas-induced corneal ulceration.
    Ellison A; Poirier R
    Am J Ophthalmol; 1976 Oct; 82(4):619-27. PubMed ID: 184711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
    Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS
    Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of tobramycin on gentamicin-resistant strains in Pseudomonas keratitis.
    Smolin G; Okumoto M; Wilson FM
    Am J Ophthalmol; 1974 Apr; 77(4):583-8. PubMed ID: 4206621
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of purulent material with antibiotics used to treat Pseudomonas infections.
    Bryant RE; Hammond D
    Antimicrob Agents Chemother; 1974 Dec; 6(6):702-7. PubMed ID: 4375433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative efficacy of the topical use of amikacin, gentamicin and tobramycin in experimental Pseudomonas keratitis.
    Davis SD; Sarff LD; Hyndiuk RA
    Can J Ophthalmol; 1980 Jan; 15(1):28-9. PubMed ID: 6769572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.